This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kondo, K. Articles by Oishi, M. Search for Related Content PubMed PubMed Citation Articles by Kondo, K. Articles by Oishi, M.

Induction of in Vitro Differentiation of Mouse Embryonal Carcinoma (F9) Cells by Inhibitors of Topoisomerases¹

Institute of Applied Microbiology, University of Tokyo, Bunkyo-ku, Tokyo 113, Japan

To investigate the possible involvement of topoisomerases in embryonal differentiation, we examined the effect of topoisomerase inhibitors on the in vitro differentiation of mouse embryonal carcinoma F9 cells. We found that camptothecin, teniposide (VM-26), or genistein, specific inhibitors of topoisomerases, induced morphological as well as biochemical changes (production of tissue plasminogen activator, synthesis of laminin, and disappearance of stage-specific embryonic antigen 1) specific to F9 cell differentiation. Since these changes were indistinguishable from those observed in F9 differentiation induced by retinoic acid (plus dibutyryl cyclic AMP), it was suggested that inhibition of cellular topoisomerase activities triggered F9 cell differentiation into parietal endoderm-like cells in the same manner as retinoic acid (plus dibutyryl cyclic AMP). Experiments using differentiation-resistant mutant F9 cell lines, however, indicated that the molecular cascade involved in topoisomerase inhibitor-induced differentiation involves different steps from those functioning in the retinoic acid-induced differentiation cascade.

¹ This work was supported by a grant from the Japanese Ministry of Education.

² To whom requests for reprints should be addressed.

Received 5/10/91. Accepted 7/17/91.

This article has been cited by other articles:

				H. Wei, R. Saladi, Y. Lu, Y. Wang, S. R. Palep, J. Moore, R. Phelps, E. Shyong, and M. G. Lebwohl Isoflavone Genistein: Photoprotection and Clinical Implications in Dermatology J. Nutr., November 1, 2003; 133(11): 3811S - 3819. [Abstract] [Full Text] [PDF]

				M.-C. Wang, J. H. Liu, and F.-F. Wang Protein Tyrosine Phosphatase-Dependent Activation of beta -Globin and delta -Aminolevulinic Acid Synthase Genes in the Camptothecin-Induced IW32 Erythroleukemia Cell Differentiation Mol. Pharmacol., April 1, 1997; 51(4): 558 - 566. [Abstract] [Full Text]

				C Perez, N. Vilaboa, L Garcia-Bermejo, E de Blas, A. Creighton, and P Aller Differentiation of U-937 promonocytic cells by etoposide and ICRF-193, two antitumour DNA topoisomerase II inhibitors with different mechanisms of action J. Cell Sci., January 2, 1997; 110(3): 337 - 343. [Abstract] [PDF]